Hlávka, Jakub P. http://orcid.org/0000-0002-2766-390X
Yu, Jeffrey C.
Goldman, Dana P.
Lakdawalla, Darius N.
Funding for this research was provided by:
National Institute on Aging (R01AG062277)
Article History
Received: 18 August 2020
Accepted: 17 February 2021
First Online: 16 March 2021
Declarations
:
: Dr. Hlávka does not report any conflicts of interest. Mr. Yu reports personal fees from Boston Health Economics. Dr. Darius Lakdawalla has received consulting fees from Amgen, Genentech, GRAIL, Novartis, Otsuka, and Pfizer. Darius Lakdawalla also holds equity in Precision Medicine Group, which provides consulting services to firms in the pharmaceutical and biotechnology industries. Dr. Goldman reports honoraria from Amgen, The Aspen Institute, and Celgene. Until March 2020, Dr. Goldman served as a scientific advisor to Precision Medicine Group, and owns < 1% equity in the company. Until November 2019, Dr. Goldman served on the scientific advisory board of ACADIA Pharmaceuticals. He currently serves on the scientific advisory board of GRAIL.
: This paper does not require institutional or ethical committee approval.